Literature DB >> 6864399

Acute rhabdomyolysis associated with hemolytic-uremic syndrome.

S P Andreoli, J M Bergstein.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6864399     DOI： 10.1016/s0022-3476(83)80782-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  Management of acute kidney injury in children: a guide for pediatricians.

Authors:  Sharon P Andreoli
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

2.  Myocarditis and haemolytic uraemic syndrome.

Authors:  I Abu-Arafeh; E Gray; G Youngson; I Auchterlonie; G Russell
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

Review 3.  Clostridium septicum myonecrosis complicating diarrhea-associated hemolytic uremic syndrome.

Authors:  Tracy E Hunley; Michele D Spring; Timothy R Peters; Douglas R Weikert; Kathy Jabs
Journal:  Pediatr Nephrol       Date:  2008-02-27       Impact factor: 3.714

4.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

Review 5.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

Review 6.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

7.  Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing.

Authors:  Stefanie W Benoit; Tsuyoshi Fukuda; Katherine VandenHeuvel; David Witte; Christine Fuller; Jennifer Willis; Bradley P Dixon; Keri A Drake
Journal:  Front Pediatr       Date:  2022-02-23       Impact factor: 3.418
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.